Castleark Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-85,280
Closed -$6.94M 354
2021
Q2
$6.94M Buy
+85,280
New +$6.86M 0.23% 117
2019
Q3
Sell
-86,889
Closed -$9.14M 370
2019
Q2
$9.14M Buy
86,889
+625
+0.7% +$62.8K 0.35% 97
2019
Q1
$9.11M Buy
86,264
+3,685
+4% +$370K 0.34% 96
2018
Q4
$6.91M Sell
82,579
-96,045
-54% -$8.7M 0.29% 102
2018
Q3
$18.2M Buy
178,624
+4,795
+3% +$463K 0.52% 50
2018
Q2
$14.1M Buy
173,829
+32,225
+23% +$2.56M 0.43% 71
2018
Q1
$10.4M Buy
+141,604
New +$10.6M 0.33% 93

Other funds holding NGVT

Castleark Management's NGVT Position: Q3 2021 in Review

Castleark Management sold out of Ingevity (NGVT) in Q3 2021, closing a stake of 85,280 shares — an estimated $6.94M sold.

Castleark Management first reported a position in NGVT in Q1 2018 and held it in 7 quarters. The position peaked at $18.2M in Q3 2018. 277 funds tracked by Wall St. Rank hold NGVT as of Q3 2021.

  • Castleark Management reported no remaining Ingevity position as of Q3 2021 after selling out during the quarter.
  • Castleark Management sold 85,280 Ingevity shares in Q3 2021, an estimated $6.94M.
  • Castleark Management first reported a position in Ingevity in Q1 2018 and held it in 7 quarters.
  • Castleark Management's Ingevity position peaked at $18.2M in Q3 2018.
  • 277 funds tracked by Wall St. Rank held Ingevity as of Q3 2021.

Based on Castleark Management's 13F filing for Q3 2021, filed 12 Nov 2021.